ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
City Therapeutics
The Vice President of Biometrics at City Therapeutics serves as the senior leader responsible for biometrics activities, encompassing biostatistics and statistical programming. This role involves establishing the biometrics infrastructure, leading a high-performing team, and driving the design, execution, and analysis of clinical trials across the company's RNAi therapeutic portfolio. The VP acts as a key strategic partner to Clinical Development, Regulatory Affairs, and Medical Affairs while managing vendor strategies and ensuring regulatory compliance for global submissions.
Company Size
1-10 employees
City Therapeutics is a biotechnology company focused on developing therapeutics for respiratory and lung diseases. The company concentrates on creating targeted, locally delivered treatments—often inhaled or airway-directed biologics and small molecules—to improve efficacy and reduce systemic side effects. City Therapeutics advances candidates from discovery through development and collaborates with academic and industry partners to translate respiratory science into clinical-stage medicines. Their mission is to transform care for patients with unmet needs in pulmonary and inflammatory disorders.
Genetic Engineering and Biotechnology NewsCity Therapeutics Pursues ‘Next Generation of RNAi’
2 weeks ago
BiogenBiogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies
May 27, 2025
BioSpaceCity Therapeutics Announces Submission of Clinical Trial Application for CITY-FXI, an Investigational RNAi Therapeutic for the Treatment of Thromboembolic Diseases
Nov 11, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for City Therapeutics.
Fierce BiotechBiogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
May 27, 2025
